Core Insights - The emergence of AI is seen as a significant opportunity for the company, contributing positively to both revenue and margin expansion over time [2] - The company’s proprietary data and domain expertise are highlighted as key assets that are being recognized in the context of AI [2] Group 1 - The company is currently operating 70 agentic modules, indicating a strong focus on AI integration and development [1] - There is a need to clarify how initial demand for AI solutions will translate into business growth [1] Group 2 - The narrative surrounding AI has led to misunderstandings about the company's data offerings, emphasizing the importance of its proprietary data in the pharmaceutical sector [2]